An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

In late-stage DAD, the researchers saw an increase of markers associated with lung fibrosis—a lung pathology that causes ...

The new study published in The American Journal of Pathology sheds light ... how mechanical forces in lung tissue contribute to and drive pulmonary fibrosis investigated the role of Piezo2 in ...

In a recent study published in the Journal of Cystic Fibrosis ... or connective tissue, or immune cells,” Ingber said. In the case of the CF airway chip, Ingber found that the epithelium was the major ...

they injected the lipid nanoparticles intravenously into a cystic fibrosis mouse model harboring the nonsense mutation, G542X. Through next-generation sequencing (NGS) of DNA extracted from its lung ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis ... become increasingly damaged by scar tissue, resulting in breathing getting progressively ...

Most of Dedra’s life was spent on the sidelines. She was diagnosed with cystic fibrosis – an inherited condition that causes mucus buildup in the lungs, and often leads to infections and damage to ...

The drugmaker has just reported the results of a phase 2 trial of oral, lysophosphatidic acid receptor 1 (LPA1) antagonist BMS-986278 in patients with progressive pulmonary fibrosis (PPF ...

Nuformix PLC on Wednesday said fresh analysis of lung tissue from patients with idiopathic pulmonary fibrosis and autoimmune-related interstitial lung disease showed "positive" results for its ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ... fibroblasts help repair lung tissue. But in people with IPF, some ...